Today: 2 July 2026
Browse Category

NYSE:PACS 26 September 2025 - 12 May 2026

PACS Group Stock Jumps as Raised EBITDA Outlook Cuts Through Regulatory Noise

PACS Group Stock Jumps as Raised EBITDA Outlook Cuts Through Regulatory Noise

PACS Group shares surged Tuesday, jumping to $39.30 in early afternoon trading in New York—a gain of $7.40, or 23.2%. After opening at $39.00, the stock hit $41.63 at its peak, and momentum held, with volume topping 2.1 million shares and prices well above the previous close. It's a straightforward story for PACS. The company surprised the market with a much simpler earnings narrative: Q1 revenue up 11.2% to $1.42 billion, net income at $80.7 million, and adjusted EBITDA surged 74.6%, landing at $170.4 million.
12 May 2026
··
PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group (PACS) Stock Soars as Q3 2025 Earnings, Restatement Cleanup and Bullish Guidance Ignite Rally

PACS Group, Inc. is back in the spotlight on Thursday after delivering strong third‑quarter 2025 results, completing a high‑stakes financial restatement process and unveiling upbeat guidance that has sent the stock to fresh 52‑week highs. PACS Group, Inc.+2Stocktwits+2 The post‑acute care operator’s shares have surged this week as investors digest a rare combination of record revenue growth, restored SEC compliance and a series of bullish analyst calls from RBC Capital and Truist Securities. Investing.com+2
20 November 2025
··
PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group (PACS) Stock Soars as Company Pledges to Clear SEC Filing Backlog by November 19, 2025

PACS Group jumps more than 40–50% after announcing plans to file all overdue SEC reports and release Q3 2025 earnings on November 19, easing delisting and default fears for the nursing-home giant. Shares of PACS Group, Inc. exploded higher on Monday after the post‑acute care operator said it will finally clear a months‑long SEC reporting backlog this week, a move seen as critical to keeping its New York Stock Exchange listing and stabilizing its financing.
17 November 2025
·
PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

PACS Group (NYSE:PACS) Pops After NYSE Reprieve—Is the Nursing‑Home Giant Finally Turning the Corner? [Sep 26, 2025]

PACS rallied into the Sep 26 close with intraday gains reported by market trackers. The surge follows two mid‑September catalysts: NYSE’s listing extension to Nov 19, 2025, giving the company runway to finish restatements and regain compliance; and a series of governance actions, including a CFO change. MarketBeat+2MarketBeat+2 Management messaging turned incrementally constructive. CEO Jason Murray said PACS expects to report “record revenue and Adjusted EBITDA for the first six months of 2025” once filings are current. Interim Chief Compliance Officer Kathy Lauer added that PACS is “taking the right steps to best position the company” during its compliance overhaul. Business Wire
26 September 2025
·

Stock Market Today

  • Yelp (YELP) Trades Above Analyst Target of $31.33
    July 2, 2026, 8:09 AM EDT. Yelp Inc (YELP) traded at $31.63, moving above the average 12-month analyst target of $31.33. That level can prompt analysts to revisit their estimates. Targets for Yelp range from $26 to $41, showing a wide split in views. The mean analyst rating is 3.76 out of 5, with no analysts calling it a buy or strong buy. Six analysts are tracked. This latest move could give investors a reason to reassess Yelp as it breaks through consensus price targets, according to Zacks Investment Research.
Go toTop